Netherlands – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – RSV-Antistoffen tbv het RIVM
openRijksinstituut voor Volksgezondheid en Milieu (RIVM) · 30276683
Value
€3
Published
14 Oct 2026
Deadline
24 Nov 2026, 11:00 GMT · 30d left · as published, verify on the notice
Type
opportunity · framework
33650000 · Medical equipment, pharmaceuticals & personal care
Description
Aanschaf van RSV Antistoffen tbv het Rijksvaccinatie programma
Key facts
- Procedure
- open
- Framework agreement
- Yes — a framework or dynamic purchasing system, not a single contract
- Submit via
- https://s2c.mercell.com/today/235581
- Contact
- rogier.de.wilde@rivm.nl
- Contract period
- 15 Jan 2026 → …
- Regime
- publicSector
- Category
- supplies
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 708478-2026
- First seen
- 14 Oct 2026
- Last updated
- 14 Oct 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/2583a49d-2edb-4df9-b7e4-e6f3e44a87c6The source notice is authoritative — verify deadlines and documents there before bidding.